ArticleHaematologica2021

Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma.

Anja Schneller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.